Background: This study was to determine whether patients with significant nighttime heartburn had more disturbed sleep and more gastroesophageal acid reflux than those without significant nighttime heartburn.
Methods: Thirty-three reflux patients were stratified into 2 groups (nighttime heartburn, without nighttime heartburn). All patients completed questionnaires assessing daytime and nighttime heartburn and subjective sleep by Pittsburgh Sleep Quality Index. All participants underwent 24-hour esophageal pH monitoring and an overnight polysomnographic study.
Results: The number of reflux events longer than 5 minutes was significantly greater in patients with nighttime heartburn than in those without nighttime heartburn for the total (P=0.004) and upright (P=0.01) position periods. Acid contact time was significantly greater in patients with nighttime heartburn during the upright (P=0.003) period and during the total (P=0.001) period. Patients with nighttime heartburn reported significantly greater subjective sleep impairment (8.1+/-0.7) than those without nighttime heartburn (6.1+/-0.4; P=0.02), but no difference could be observed in any objective sleep parameter by an overnight polysomnographic study between the groups.
Conclusions: Patients with significant nighttime heartburn seem to have more acid reflux compared with those without nighttime heartburn. Nighttime heartburn together with sleep complaints is associated with excessive gastroesophageal reflux.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MCG.0b013e31802fc1bc | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment Response With Potassium-competitive Acid Blockers Based on Clinical Phenotypes of Gastroesophageal Reflux Disease: A Systematic Literature Review and Meta-analysis.
J Neurogastroenterol Motil
July 2024
Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.
Background/aims: Gastroesophageal reflux disease (GERD) is typically managed based on the clinical phenotype. We evaluated the efficacy and safety of potassium-competitive acid blockers (PCABs) in patients with various clinical GERD phenotypes.
Methods: Core databases were searched for studies comparing PCABs and proton pump inhibitors (PPIs) in clinical GERD phenotypes of erosive reflux disease (ERD), non-erosive reflux disease (NERD), PPI-resistant GERD and night-time heartburn.
Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial.
Clin Gastroenterol Hepatol
November 2024
Weill Cornell Medicine, New York, New York.
Background & Aims: Potassium-competitive acid blockers have documented efficacy for erosive esophagitis. We performed a randomized trial in United States subjects diagnosed with non-erosive reflux disease of vonoprazan vs placebo for 4 weeks, followed by a 20-week active-treatment extension.
Methods: Adult subjects with heartburn ≥4 days/week during screening without erosive esophagitis on endoscopy were randomized to placebo, vonoprazan 10 mg, or vonoprazan 20 mg.
Dyspepsia - The Indian perspective: A cross sectional study on demographics and treatment patterns of Dyspepsia from across India (Power 1.0 study).
J Assoc Physicians India
April 2023
Head, Department of Medical Affairs, Dr Reddys Laboratories, Telangana, Hyderabad, India.
Background: Dyspepsia includes a spectrum of symptoms ranging from epigastric pain and early satiety to postprandial fullness. The worldwide prevalence of dyspepsia is 20-30%. It is slightly higher in the Western population and occurs more frequently among women.
View Article and Find Full Text PDFEffects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial.
J Neurogastroenterol Motil
January 2023
HK inno.N Corp, Seoul, Korea.
Article Synopsis
- The study aims to compare the effectiveness of tegoprazan, a new acid blocker, with esomeprazole in relieving nighttime heartburn and sleep disturbances in patients with gastroesophageal reflux disease (GERD).
- A total of 46 patients participated, receiving either tegoprazan 50 mg or esomeprazole 40 mg for 2 weeks, and although tegoprazan showed a faster time to first nighttime heartburn-free interval, the difference was not statistically significant.
- The results suggest that while tegoprazan might provide quicker relief from nighttime heartburn, more extensive studies are needed to confirm these findings due to the small sample size and significant limitations in statistical significance.
[A simple home remedy for heartburn led to a life-threatening rupture of the stomach].
Lakartidningen
July 2022
docent, överläkare, kirurgiska kliniken, Visby lasarett.
A middle-aged male who suffered from heartburn ingested 1 tablespoon of bicarbonate dissolved in water to relieve symptoms. Minutes afterwards he debuted with severe abdominal pain. Upon arrival at hospital 35 minutes later he was septic with peritonitis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!